Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Krystal Biotech, Inc.

Announce data from the GLP toxicology study of inhaled KB407

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
1 Mar 2021
Due
30 Jun 2021
Delivered
19 Apr 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“the Company plans to announce data from the study in 1H21”

What we found

Evidence strength A What the grades mean

A 10-Q filed August 2021 states the company announced positive preclinical data from the GLP toxicology and biodistribution study on April 19, 2021, before the June 30, 2021 deadline.

  • A
    Krystal Biotech, Inc. 10-Q filed 2021-08-09 Regulatory filing · published 9 Aug 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “On April 19, 2021, we announced positive preclinical data from the Good Laboratory Practice toxicology and biodistribution study” ✓ confirmed on the page
  • A
    Krystal Biotech, Inc. 10-K filed 2022-02-28 Regulatory filing · published 28 Feb 2022 · retrieved 26 Oct 2026 · kept permanently by the SEC
    “More detailed data from the Good Laboratory Practice "GLP" toxicology and biodistribution study was presented at the virtual 2021 North American Cystic Fibrosis Conference” ✓ confirmed on the page

Checked 26 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Announce
Deliverable
Data from KB407 GLP repeat-dose toxicology study
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Krystal Biotech, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-KRYS-024832 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.